Table 2.
Association Between Frailty, Symptom-Burden and Health-Related Quality of Life
| Unstandardised β Coefficient |
SE | Unadjusted P Value | |
|---|---|---|---|
| KSQ total frequency score | |||
| - Frailty | 9.28 | 1.01 | < 0.001* |
| - Age | 0.04 | 0.05 | 0.39 |
| - Female | 3.69 | 1.00 | < 0.001* |
| - eGFR | −0.15 | 0.05 | 0.004* |
| Haemoglobin | 0.03 | 0.03 | 0.41 |
| SF-12 PCS score | |||
| - Frailty | −13.57 | 1.12 | < 0.001* |
| - Age | −0.18 | 0.06 | 0.002* |
| - Female | −2.19 | 1.11 | 0.05 |
| - eGFR | 0.16 | 0.06 | 0.007* |
| - Haemoglobin | −0.02 | 0.03 | 0.48 |
| SF-12 MCS score | |||
| - Frailty | −3.85 | 1.14 | 0.001* |
| - Age | 0.13 | 0.06 | 0.03 |
| - Female | −3.80 | 1.09 | < 0.001* |
| - eGFR | 0.07 | 0.06 | 0.23 |
| - Haemoglobin | 0.01 | 0.03 | 0.80 |
*Remain statistically significant following Bonferroni correction
KSQ Kidney Symptom Questionnaire, SF-12 Short Form-12